TREX1 and cancer: In recent years, interest in TREX1 has risen due to its potential as a cancer immunotherapy target (23), and TREX1 activity on ss- versus dsDNA, the purpose of its homodimer structure, and the source of TREX1’s DNA substrates in vivo remain areas of active interest (24, 25).